weight management

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

February 6, 2026

Hims An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,…

FFitness

What 10,000 Steps a Day Gets Right (and Wrong) About Health and Weight

February 5, 2026

If you’ve ever tracked your steps with a wearable fitness tracker, a smartwatch, or the pedometer built into…

MMedication

January 29, 2026

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…

MMedication

January 16, 2026

Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead MarketWatchThe Truth…

MMedication

Popular weight-loss drugs shouldn't carry suicide warnings, FDA says

January 14, 2026

Federal regulators on Tuesday told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal…

MMedication

Weight loss drug Wegovy to be listed on PBS

January 13, 2026

Wegovy will be heavily subsidised for Australians with severe obesity, who have also experienced a cardiovascular event, like…

NNutrition

I’m a Dietitian Taking a GLP-1. These Are My Go-To Simple Meals

January 11, 2026

Friday tradition: Every Friday, without fail, I get a Dunkin’ Donuts egg and cheese on an everything bagel…

NNutrition

January 9, 2026

December’s highlights include FrieslandCampina Ingredients’ planned expansion of its whey protein business and North American footprint, research findings…

MMedication

After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss

December 21, 2025

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading…

MMedication

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

December 16, 2025

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…

NNutrition

Nutritionist shares winter special gluten-free, fibre-rich paratha recipe for weight loss with zero refined flour

December 15, 2025

Updated on: Dec 15, 2025 05:14 pm IST If you were looking for a healthy paratha recipe to…

HHealthcare

Max Healthcare endocrinology head tells Amitabh Bachchan how to stay fit: ‘Obesity modern chronic disease ki janani hai’

November 29, 2025

Obesity is one of the most common health problem that India faces. Around 18 crore Indians are chronic…

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

What 10,000 Steps a Day Gets Right (and Wrong) About Health and Weight

US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy

Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead – MarketWatch

Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says

Weight loss drug Wegovy to be listed on PBS

I’m a Dietitian Taking a GLP-1. These Are My Go-To Simple Meals

WHO guidance on GLP-1, nutrition innovations for longevity and the global omega-3 gap

After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss

Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

Nutritionist shares winter special gluten-free, fibre-rich paratha recipe for weight loss with zero refined flour

Max Healthcare endocrinology head tells Amitabh Bachchan how to stay fit: ‘Obesity modern chronic disease ki janani hai’